Search

Your search keyword '"Primary Graft Dysfunction etiology"' showing total 513 results

Search Constraints

Start Over You searched for: Descriptor "Primary Graft Dysfunction etiology" Remove constraint Descriptor: "Primary Graft Dysfunction etiology"
513 results on '"Primary Graft Dysfunction etiology"'

Search Results

1. Update on the immunological mechanisms of primary graft dysfunction and chronic lung allograft dysfunction.

2. Dynamic associations between adverse events after lung transplantation and allograft ischaemic time.

3. Adult living-donor lobar lung transplant using a small-for-size graft.

4. Airway epithelium in lung transplantation: a potential actor for post-transplant complications?

5. Veno-Venous Extracorporeal Membrane Oxygenation Support for Severe Primary Graft Dysfunction Is Associated With Reduced Airway Complications After Lung Transplantation.

6. The Effects of Volatile Anesthetics on Early Clinical Outcomes in Liver Transplantation: A Systematic Review and Meta-Analysis.

7. Serum Arginine Level for Predicting Early Allograft Dysfunction in Liver Transplantation Recipients by Targeted Metabolomics Analysis: A Prospective, Single-Center Cohort Study.

8. Murine orthotopic lung transplant models: A comprehensive overview of genetic mismatch degrees and histopathological insights into chronic lung allograft dysfunction.

9. Clinical characteristics and outcomes of lung transplantation in patients with severe COVID-19 infection: A systematic review and meta-analysis.

10. Validation and performance of three scoring systems for predicting primary non-function and early allograft failure after liver transplantation.

11. Donor plasma VEGF-A as a biomarker for myocardial injury and primary graft dysfunction after heart transplantation.

12. IRF1 and IL1A associated with PANoptosis serve as potential immune signatures for lung ischemia reperfusion injury following lung transplantation.

13. Comparing right- versus left-first implantation in off-pump sequential double-lung transplantation: an observational cohort study.

14. Necropsy findings in heart transplant recipients with or without primary graft dysfunction.

15. Baseline lung allograft dysfunction after bilateral deceased-donor lung transplantation: A single-center experience in Japan.

16. Ex vivo lung perfusion in donation after circulatory death: A post hoc analysis of the Normothermic Ex Vivo Lung Perfusion as an Assessment of Extended/Marginal Donors Lungs trial.

17. Extreme elevations of donor-derived cell-free DNA increases the risk of chronic lung allograft dysfunction and death, even without clinical manifestations of disease.

18. Effects of Intraoperative Support Strategies on Endothelial Injury and Clinical Lung Transplant Outcomes.

19. Early Graft Loss With Suspected Seventh-Day Syndrome Following Pediatric Liver Transplantation.

20. Donor Fractions of Cell-Free DNA Are Elevated During CLAD But Not During Infectious Complications After Lung Transplantation.

21. A Case of Primary Renal Allograft Dysfunction Caused by Missed Monoclonal Disease.

22. Increased Donor Organ Size and Age is Associated with Reduced Survival in Female Lung Transplant Recipients.

23. The diagnosis and management of chronic lung allograft dysfunction.

24. Impact of controlled hypothermic preservation on outcomes following heart transplantation.

25. Systemic Inflammation Differences in Brain-vs. Circulatory-Dead Donors: Impact on Lung Transplant Recipients.

26. Impact of Acute Exacerbation of Idiopathic Pulmonary Fibrosis on Lung Transplant Outcomes.

28. Airway pepsinogen A4 identifies lung transplant recipients with microaspiration and predicts chronic lung allograft dysfunction.

29. Primary graft dysfunction in heart transplantation: the challenge to survival.

30. An integrated proteomics and metabolomics approach to assess graft quality and predict early allograft dysfunction after liver transplantation: a retrospective cohort study.

31. Lung Transplantation in Pulmonary Arterial Hypertension: The Portuguese Experience.

32. Driving pressure association with mortality in post-lung transplant patients: A prospective observational study.

33. The International Consortium on Primary Graft Dysfunction: Redefining Clinical Risk Factors in the Contemporary Era of Heart Transplantation.

34. Proteomic Analysis of Primary Graft Dysfunction in Porcine Lung Transplantation Reveals Alveolar-Capillary Barrier Changes Underlying the High Particle Flow Rate in Exhaled Breath.

35. Impact of the New Definition of Pulmonary Hypertension on the Prevalence of Primary Graft Dysfunction in Lung Transplant Recipients.

36. Long-Term Survival Following Primary Graft Dysfunction Development in Lung Transplantation.

37. Temporal correlation between postreperfusion complement deposition and severe primary graft dysfunction in lung allografts.

38. Restrictive allograft dysfunction rather than bronchiolitis obliterans syndrome had a major impact on the overall survival after living-donor lobar lung transplantation.

39. Developing machine learning models to predict primary graft dysfunction after lung transplantation.

40. HLA sensitization is associated with an increased risk of primary graft dysfunction after heart transplantation.

41. The Predictive Value of Graft Viability and Bioenergetics Testing Towards the Outcome in Liver Transplantation.

42. Donor and recipient risk factors for the development of primary graft dysfunction following lung transplantation.

43. Association of cardiac preservation solution with short-term outcomes after heart transplantation.

44. Computed Tomography Volumetrics for Size Matching in Lung Transplantation for Restrictive Disease.

45. Comparison of Prognosis for Lung Transplantation between Older and Younger Donors: A Systematic Review and Meta-Analysis Based on Cohort Studies.

46. Use of Extracorporeal Membrane Oxygenation for Primary Graft Dysfunction After Cardiac Transplantation: Results of an A Priori Ventless Approach.

47. Postreperfusion Pulmonary Artery Pressure Indicates Primary Graft Dysfunction After Lung Transplant.

48. Prognosis of Lung Transplantation in Patients with Acute Exacerbations of Interstitial Lung Disease: A Meta-Analysis Based on Cohort Studies.

49. Effect of antifibrotic agents on postoperative complications after lung transplantation for idiopathic pulmonary fibrosis.

50. The role of lung microbiota in primary graft dysfunction in lung transplant recipients.

Catalog

Books, media, physical & digital resources